Sun to acquire Ranbaxy in US$4.0 bn deal

10 April 2014 - Deborah Wilkes

Archived

India's Sun Pharmaceutical Industries has agreed to acquire Ranbaxy Laboratories, including its Global Consumer Healthcare division, from Japan's Daiichi Sankyo in an all-share deal worth US$4.0 billion.

Click tags below for more information on topics:

Daiichi Sankyo

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: